Latitude Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Latitude Advisors's ELV Position: Q3 2026 in Review
Latitude Advisors reduced its Elevance Health (ELV) stake by 2.9% in Q3 2026, selling an estimated $8.78K and leaving 743 shares worth $289K. The position accounts for 0.09% of the portfolio, ranked #200.
Latitude Advisors first reported a position in ELV in Q4 2020 and has held it in 24 quarters since. The position peaked at $1.17M in Q1 2022. 1,626 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- Latitude Advisors held 743 shares of Elevance Health worth $289K as of Q3 2026.
- Latitude Advisors sold 22 Elevance Health shares in Q3 2026, an estimated $8.78K.
- Elevance Health made up 0.09% of Latitude Advisors's portfolio in Q3 2026, its #200 holding.
- Latitude Advisors first reported a position in Elevance Health in Q4 2020 and has held it in 24 quarters since.
- Latitude Advisors's Elevance Health position peaked at $1.17M in Q1 2022.
- 1,626 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on Latitude Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.